Levetiracetam and Lacosamide in epilepsy patients
Introduction Conventional anti‑epileptic first‑line drugs can control the seizures of most patients with epilepsy, but persistent seizures occur in more than 30% of patients. Lacosamide, an antiepileptic drug, has been used as an adjuvant treatment for partial or systemic epilepsy. Objective To evaluate the therapeutic effect of levetiracetam combined with Lacosamide in patients with epilepsy. […]
Management of drug-resistant focal epilepsy with Levetiracetam
Introduction Epilepsy affects over 70 million people worldwide. With the evolving resistance of focal epilepsy, there is need for add-on therapies for better clinical outcomes. Objectives To evaluate the effectiveness of levetiracetam as an add-on treatment for people with drug-resistant focal epilepsy. Search methods The Cochrane Register of Studies (CRS Web, which includes the Cochrane […]